NormOxys, Inc., is a biotechnology company developing a new class of small molecule drugs which are derivatives of polyol phosphates. This platform promises to offer breakthrough treatments for a wide variety of cancers.
Pierre Fabre has been a major player in dermatology for over 40 years and has had over 45 years of experience in the pharmaceutical industry. Pierre Fabre's rigor and pharmaceutical know how shines in top expertise in research and development, offering scientific solutions that guarantee optimal tolerance and efficacy. Health and safety are at the core of all of Pierre Fabre’s formulations. Research, innovation, ethical and pharmaceutical rigour, a commitment to public health, scientific cosmetics of the highest level. It is thanks to these strong values, cultivated by the firm for over…
BioHiTech is using technology to open new opportunities in an industry that has gone unchanged for almost 50 years. BioHiTech offers customers a more cost-effective and technologically innovative solution compared to traditional disposal. This approach will help reduce the generation of waste as well as reduce costs and increase recycling rates.
DiscGenics is a spinal therapeutics company developing proprietary adult human disc stem cells with a tissue engineering approach to treat patients debilitated by Degenerative Disc Disease.Degenerative Disc Disease affects millions of people worldwide. This debilitating condition results in the progressive breakdown of the intervertebral disc, which supports the spine and allows for pain free motion. DiscGenics is developing new approaches to regenerating the intervertebral disc using stem cells and tissue engineering.
Richmond Chemical Corporation is a chemical and biosciences company, established in 2000 by a team of former Monsanto employees with over 17 years experience in bringing chiral chemistry and bioscience technologies to the pharma marketplace. The company, headquartered in Illinois, is engaged in the manufacturing, distribution and sourcing of pharmaceutical and chemical intermediates, while also practicing innovative applied research.
Extera Partners has grown to become one of the largest and most active life science corporate development firms. They specialize in the planning for and execution of strategic transactions with life science industry partners and financial investors across the globe. Extera Partners is focused on meeting the evolving business needs of our clients, projects and investors with a steady eye towards opportunities that maximize shareholder value. They deliver expert, yet practical, business leadership, strategic advice, aggressive execution in business and corporate development, sales and…
BUILDING THE LEADING BRAND IN PERSONALIZED HEALTH & WELLNESS LIFESTYLE.We're bringing innovation to a massive and underserved industry.While innovation for most areas of our lifes has exploded, beauty, health & wellness has gone 10 years without true innovation.BEAUTY, DIET, FITNESS, AGE-MANAGEMENT CROSS-OVERBecause the population is rapidly growing and aging, the global market for anti-aging products, technologies and services is forecast to grow from $282 billion in 2015 to $331 billion in 2020 as projected by the Global Wellness Institute.OUR GOAL IS TO PROVIDE PERSONALIZED HEALTH &…
CardioCreate is a regenerative medicine company pioneering new treatments for heart disease. Unlike conventional therapies that treat the symptoms, CardioCreate’s engineered stem cells can actually rebuild damaged heart tissue and restore cardiac function. The company is currently generating preclinical data that it hopes will enable first-in-man testing within the next several years.
Cloud Pharmaceuticals Inc. is an in silico therapeutics company with a unique discovery capability. The company designs and develops new drugs for a wide range of therapeutic areas including cancer, inflammation, CNS disorders, and rare diseases. Cloud Pharmaceuticals partners extensively throughout its development process. We use our proprietary methods, along with a network of virtual partners, to fill the need that bio/pharma companies have for rapid development of new active molecules. Cloud Pharmaceuticals is a leader in the computational design of new drugs and subsequent rapid,…
Prescient was founded in London in 1995, originally specializing in competitive insights. Since then, we have expanded and diversified to become a leading evidence-based decision-support partner to the biopharmaceutical sector. With offices in North America, Europe and Asia, we offer a global perspective, helping clients to succeed in both mature and emerging markets.
XL TechGroup, Inc. is engaged in the creation and development of new businesses in the areas of BioTech, EcoTech and MedTech sectors. The Company’s portfolio includes TyraTech, Inc. (45.5% owned by XL TechGroup), DxTech LLC (83.7%), GenXL LLC (43.3%), PetroAlgae LLC (94.6%) and QuoNova LLC (88.7%). TyraTech is engaged in the development of a new class of non-toxic, pesticides and anti-parasitic compounds. DxTech is developing a point-of-care diagnostics platform that combines reference lab quality, in real time, with a planned menu of tests. GenXL LLC was established as a joint venture…
Vaxess Technologies is a venture-backed life sciences company developing novel heat-stable vaccine formulations based on its proprietary silk stabilization platform. We are committed to improving access to vaccines by enabling truly global products that can be more effectively delivered throughout both the developed and developing world.
pH Sciences was founded to develop safe and affordable products that control excess acidity throughout the body. pH Sciences holds intellectual property and patents to manufacture a wide range of proprietary mineral based, crystalline compositions that can safely control the complex alkaline balance in human and other biological systems.pH levels are fundamental to health, vitality and performance of all biological systems. pH Sciences continues to build expertise in developing new technologies, new products and safe ingredients to manage biological pH levels.
Celling Biosciences is advancing the future of medicine through the innovation of point-of-care, autologous regenerative cell therapies. Our dedicated team of scientists, engineers and physicians are focused on developing point-of-care systems, innovative surgical techniques and technology platforms that create the optimal environment for regenerative cell therapies to promote healing and the regeneration of tissue.
Dyadic International, Inc. (OTC Pink: DYAI) is a global biotechnology company located in Jupiter, Florida with its main research and development operations located in The Netherlands. Dyadic is focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, biochemical, industrial enzyme and biopharmaceutical industries.
In 2007, Fytozimus Biotech Inc., was formed to meet dairy manufacturers' needs for a more natural, flexible and environmentally conscious approach to the creation of their products.With its corporated headquarters located in the economically strong region of Edmonton, Alberta, Canada and its research offices in historic Lisbon, Portugal, Fytozimus is well positioned to expand globally.Product testing has already been completed in Europe and North Africa and has, based on positive results, now reached the commercialization stage in North America.Fytozimus' plant-based products offer the…
RAFAGEN’s primary focus is the development and commercialization of next generation gene expression systems with applications in solving the most challenging problems in molecular therapeutics. RAFAGEN will leverage its core technology to build up a strategic framework for revenue generation in licensing deals and service contracts, and eventually, for its own development of highly effective molecular therapy drugs.
BioBlend lubricants made their debut in the field in 2001. Since then, we've continued to innovate and expand our product line to include not only biobased lubricants, but also food grade and synthetic lubricants. BioBlend's goal is to provide environmentally responsible products and solutions to a wide range of industries. Our customers come to us from every corner of the earth and in every industry: drilling, mining, construction, agriculture, marine, food processing, government, and many more...Our team at BioBlend has a wealth of experience in lubricants, manufacturing, and…
GLO Science's vision is to be the most transformative and globally leading oral health, wellness, and beauty company as it relates to the smile. 11 patents and 19 patent applications around a Class 1 medical device, GLO Science strives to become the Apple of oral care. Our "intentionally different" approach to oral health and beauty care is making a real difference in the consumer behavior and acceptance of new treatment and oral care products and services. Focused on the professional dental channel and the prestige beauty channel, the GLO technology creates a delivery system for a unique…
